HR 843 · 119th CongressIn Committeecongress.gov ↗
What this bill does
AI plain-language summaryThis bill allows the Food and Drug Administration to approve generic drugs even when their labels don't include certain safety information that is protected by patents or exclusivity rights of other drugs. Currently, generic drug labels must generally be identical to the original drug's label. The bill creates an exception to this rule when safety information is protected by patents. However, the FDA must still require generic drug labels to include any safety information that is necessary for safe use.
Your Vote
Discussion (0)
Explain what is at stake in this bill.
Sign in to join the discussion.
No comments yet. Be the first.